NewKerala.com

Key Points

US pharmaceutical giant Eli Lilly is making a massive $1 billion investment in India over the coming years. Commerce Minister Piyush Goyal welcomed this move, highlighting India's growing position as a global innovation hub. The investment will establish new manufacturing facilities in Hyderabad, creating thousands of local jobs. This strategic expansion will focus on producing medicines for diabetes, obesity, cancer and other critical health conditions.

Key Points: Piyush Goyal Welcomes Eli Lilly $1 Billion India Investment

  • One of largest foreign investments in India's healthcare manufacturing sector
  • Will create thousands of job opportunities for Telangana's youth
  • Strengthens Hyderabad's position as global life sciences hub
  • Focuses on medicines for diabetes, obesity, cancer and Alzheimer's
  • Expands manufacturing capacity and global supply operations
  • Comes after Eli Lilly delegation met Telangana Chief Minister
2 min read

Piyush Goyal welcomes Eli Lilly's USD 1 billion investment in India

US pharma giant Eli Lilly announces $1 billion investment in India, creating thousands of jobs in Hyderabad and strengthening India's healthcare manufacturing sector.

"We welcome @EliLillyandCo's $1bn investment in India! This reaffirms our nation's position as a global hub for innovation - Piyush Goyal"

New Delhi, October 9

US-based pharmaceutical company Eli Lilly and Company has announced plans to invest more than USD one billion in India over the next several years, marking one of the largest foreign investments in the country's healthcare manufacturing sector in recent years. Union Minister of Commerce and Industry, Piyush Goyal, welcomed the investment and highlighted the growing presence of India in the global ecosystem.

On Wednesday, in a post on X, Goyal said, "We welcome @EliLillyandCo's $1bn investment in India! This reaffirms our nation's position as a global hub for innovation, R&D, manufacturing, and healthcare solutions. Under PM @NarendraModi ji's leadership, India has made remarkable progress in enhancing Ease of Doing Business and building global trust in its quality ecosystem that has made it one of the most preferred investment destinations."

Eli Lilly and Company (India) has announced plans to invest in new contract manufacturing in India, thereby expanding patients' access to innovative medicines worldwide.

This strategic investment will further strengthen manufacturing and supply capabilities to support Lilly's evolving portfolio. In addition, the company will establish a new Manufacturing and Quality presence in Hyderabad.

The move is expected to create thousands of job opportunities for the state's youth and further strengthen Hyderabad's position as a global life sciences and pharmaceutical hub.

The announcement came after a delegation from Eli Lilly met Chief Minister A Revanth Reddy and Industries Minister D. Sridhar Babu at the Integrated Command Control Centre on Monday.

This latest investment, one of the largest in recent years, comes just months after the inauguration of Eli Lilly's Global Capability Centre (GCC) in Hyderabad on August 4. The new facilities will expand the company's manufacturing capacity and global supply operations, focusing on medicines to treat diabetes, obesity, cancer, Alzheimer's disease, and autoimmune conditions.

"Telangana means business. Hyderabad is a global city. Our government will support and welcome all industries looking to invest here," said Chief Minister Revanth Reddy, reaffirming the state's commitment to fostering a conducive environment for global investors.

The Chief Minister thanked the Eli Lilly leadership for choosing Telangana and assured full government support for future expansions.

- ANI

Share this article:

Reader Comments

R
Rohit P
Great to see global giants recognizing India's potential. Hope this leads to more affordable medicines for diabetes and other chronic conditions that affect millions of Indians.
A
Arjun K
While I welcome the investment, I hope the government ensures that local companies also get fair opportunities and that the benefits reach the common people, not just corporate profits.
S
Sarah B
As someone working in the pharma sector, this is exactly the kind of boost we need. The focus on R&D and manufacturing will elevate India's position in global healthcare. Well done!
M
Michael C
Impressive investment! Eli Lilly choosing India over other Asian countries shows how much our business environment has improved. Make in India is working! 💪
N
Nikhil C
Hope the local communities in Hyderabad benefit from this. Sometimes these big investments don't trickle down to the people who need it most. The government should monitor this closely.
K
Kavya N
This is wonderful for Telangana's economy! The focus on diabetes and obesity medicines is particularly relevant given India's growing health challenges. More such investments please! 🙏

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50